Filing Details

Accession Number:
0001209191-21-009047
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-09 19:56:00
Reporting Period:
2021-02-05
Accepted Time:
2021-02-09 19:56:00
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1785345 Landos Biopharma Inc. LABP () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1678736 Konstantin Poukalov C/o Landos Biopharma, Inc.
1800 Kraft Drive, Suite 216
Blacksburg VA 24060
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-02-05 27,453 $11.14 14,647,181 No 4 P Indirect By funds
Common Stock Acquisiton 2021-02-08 34,611 $11.38 14,681,792 No 4 P Indirect By funds
Common Stock Acquisiton 2021-02-08 86,671 $12.53 14,768,463 No 4 P Indirect By funds
Common Stock Acquisiton 2021-02-08 1,771 $13.10 14,770,234 No 4 P Indirect By funds
Common Stock Acquisiton 2021-02-09 64,730 $13.80 14,834,964 No 4 P Indirect By funds
Common Stock Acquisiton 2021-02-09 34,951 $14.60 14,869,915 No 4 P Indirect By funds
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By funds
No 4 P Indirect By funds
No 4 P Indirect By funds
No 4 P Indirect By funds
No 4 P Indirect By funds
No 4 P Indirect By funds
Footnotes
  1. The prices reported in Column 4 are weighted average prices. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges of the prices reported on this Form 4.
  2. These shares were purchased in multiple transactions at prices ranging from $11.05 to $11.75, inclusive.
  3. Securities are held by Perceptive Life Sciences Master Fund, Ltd. ("PLSMF"), Perceptive Xontogeny Venture Fund, LP ("PXVF"), and PX Venture (A), LLC ("PXV"). Perceptive Advisors, LLC ("Perceptive Advisors") serves as the investment manager to PLSMF, PXVF, and PXV. The Reporting Person is a managing director of Perceptive Advisors. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
  4. These shares were purchased in multiple transactions at prices ranging from $10.96 to $11.93, inclusive.
  5. These shares were purchased in multiple transactions at prices ranging from $11.96 to $12.95, inclusive.
  6. These shares were purchased in multiple transactions at prices ranging from $13.09 to $13.10, inclusive.
  7. These shares were purchased in multiple transactions at prices ranging from $13.17 to $14.16, inclusive.
  8. These shares were purchased in multiple transactions at prices ranging from $14.17 to $15.20, inclusive.